[1]Bhatt MP, Lim YC, Ha KS. C-peptide replacement therapy as an emerging strategy for preventing diabetic vasculopathy[J]. Cardiovasc Res,2014, 104(02): 234-244.
[2]Hu YH, Hou J, Zheng DZh, et al. Protection and mechanism of shenqi compound for diabetic angiopathy model rats[J]. Chinese Journal of Integrated Traditional and Western Medicine,2014, 34(9): 1078-1085. (in Chinese)
呼永河,侯君,郑德志,等. 参芪复方对糖尿病模型大鼠血管病变的保护作用及机制[J]. 中国中西医结合杂志, 2014, 34(9): 1078-1085.
[3] Huang S, Chen L, Lu L, et al. The apelin-APJ axis: A novel potential therapeutic target for organ fibrosis[J]. Clin Chim Acta, 2016, 456: 8188.
[4]Wang LY, Ding JX, Zhang DL, et al. Apelin/APJ and organ fibrosis[J]. Chinese General Practice, 2013, 16(7): 2424-2426. (in Chinese)
王丽妍,丁嘉祥,张东亮,等. Apelin/APJ系统与器官纤维化关系的研究进展[J]. 中国全科医学, 2013, 16(7): 2424-2426.
[5]Wu D, He L, Chen L. Apelin/APJ system: a promising therapy target for hypertension[J]. Mol Biol Rep,2014, 41(10): 6691-6703.
[6]Kuai M, Li Y, Sun X, et al. A novel formula Sang-Tong-Jian improves glycometabolism and ameliorates insulin resistance by activating PI3K/AKT pathway in type 2 diabetic KKAy mice[J]. Biomed Pharmacother,2016, 84: 1585-1594.
[7]Yin H, Wang W, Yu W, et al. Changes in synaptic plasticity and glutamate receptors in type 2 diabetic KK-Ay mice[J]. J Alzheimers Dis,2017,57(4):1207-1220.
[8]Wang L, Zhao XC, Cui W, et al. Genetic and pharmacologic inhibition of the chemokine receptor CXCR2 prevents experimental hypertension and vascular dysfunction[J]. Circulation, 2016, 134(18): 1353-1368.
[9]Zhang BH, Guo CX, Wang HX, et al. Cardioprotective effects of adipokine apelin on myocardial infarction[J]. Heart Vessels, 2014, 29(5): 679-689.
[10]Wei ShN, Zeng XJ, Li HH. Improvement of masson staining in renal fibrosis of mice[J]. Acta Anatomica Sinica, 2013,44(4): 576-579. (in Chinese)
魏胜男,曾翔俊,李汇华. 小鼠肾脏纤维化Masson染色方法的改进[J]. 解剖学报, 2013,44(4): 576-579.
[11]Ren J, Yang M, Qi G, et al. Proinflammatory protein CARD9 is essential for infiltration of monocytic fibroblast precursors and cardiac fibrosis caused by Angiotensin Ⅱ infusion[J]. Am J Hypertens, 2011, 24(6): 701-707.
[12]Yang K, Zhang TP, Tian C, et al. Carboxyl terminus of heat shock protein 70-interacting protein inhibits angiotensin Ⅱ-induced cardiac remodeling[J]. Am J Hypertens, 2012, 25(9): 994-1001.
[13]Hu H, He L, Li L, et al. Apelin/APJ system as a therapeutic target in diabetes and its complications[J]. Mol Genet Metab, 2016, 119(1-2): 20-27.
[14]Li DD, Zhang Zh, Liu ZD. Mechanism on prevention and treatment effect of Apelin-13 for myocardial fibrosisin type 2 diabetic rats [J]. Chinese Journal of Arteriosclerosis, 2014, 22(10): 1009-1014. (in Chinese)
林朵朵,张志,刘紫东. Apelin-13对2型糖尿病大鼠心肌纤维化防治的作用机制[J]. 中国动脉硬化杂志, 2014, 22(10): 1009-1014.
[15]Li HQ, Zhang Zh, Jiao H, et al. Effect of apelin-13 on myocardial fibrosis in diabetic rats[J]. Academic Journal of Pla Postgraduate Medical School, 2013, 34(6): 621-624. (in Chinese)
里宏晴,张志,焦慧,等. Apelin-13对糖尿病大鼠心肌纤维化的影响[J]. 解放军医学院学报, 2013, 34(6): 621-624.
[16]Xu R, Zhang ZZ, Chen LJ, et al. Ascending aortic adventitial remodeling and fibrosis are ameliorated with Apelin-13 in rats after TAC via suppression of the miRNA-122 and LGR4-beta-catenin signaling[J]. Peptides, 2016, 86: 85-94.
[17]Wei C, Shen E, Hu B. Advances in research of macroangiopathy in diabetes[J]. Journal of Shanghai Jiaotong University (Medical Science), 2010, 30(10): 1292-1296. (in Chinese)
魏聪,申锷,胡兵. 糖尿病大血管病变的研究进展[J]. 上海交通大学学报(医学版), 2010, 30(10): 1292-1296.
[18]Wang J, Xu Y, Yuan XK, et al. TGF-β1 and CTGF expression and intervention of traditional Chinese medicine in experimental diabetic rats of macrovascular disease[J]. Tianjin Journal of Traditional Chinese Medicine, 2012, 29(3): 266-269. (in Chinese)
王军,徐阳,袁向科,等. 实验性糖尿病鼠大血管病变TGF-β1和CTGF的表达及中药的干预作用[J]. 天津中医药, 2012, 29(3): 266-269.
[19]Kovanecz I, Nolazco G, Ferrini MG, et al. Early onset of fibrosis within the arterial media in a rat model of type 2 diabetes mellitus with erectile dysfunction[J]. BJU Int, 2009, 103(10): 1396-1404.
[20]Robert L, Jacob MP, Frances C, et al. Interaction between elastin and elastases and its role in the aging of the arterial wall, skin and other connective tissues[J]. A Review Mech Ageing Dev,1984, 28(2-3):155-166.
[21]Zeng WJ, Chen Ch, Huang ShA. Role of transforming growth factor-β and its signaling transduction in the process of vascular fibrosis[J]. Medical Recapitulate, 2008,14(3): 332-334. (in Chinese)
曾伟杰,陈灿,黄石安. 血管纤维化过程中TGF-β及信号转导的作用[J]. 医学综述, 2008,14(3): 332-334.
[22]Wang YN, Lin C, Ren Q, et al. Astragaloside effect on TGF-β1, SMAD2/3, and α-SMA expression in the kidney tissues of diabetic KKAy mice[J]. Int J Clin Exp Pathol, 2015, 8(6):6828-6834.
|